2HRA Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Operational RecoveryThe rebound in revenue and operating margin indicates improved earnings momentum after the 2025 downturn. Sustaining this recovery could strengthen profitability and provide a better base for serving industrial customers over the next several quarters.
Specialty Product PortfolioH&R serves multiple industrial applications with specialized refinery and chemical products rather than relying solely on fuels. This product breadth and application knowledge can support customer relationships, mix optimization and resilience across end-markets.
Positive Operating Cash FlowPositive operating cash generation and a substantial equity base provide ongoing support for operations and investment. Although cash conversion is imperfect, these resources offer financial capacity to maintain production and pursue specialty-market opportunities.
Bears Say
Very Thin ProfitabilityThe small bottom-line margin leaves limited protection against feedstock, energy, pricing or demand pressures. Even with operating improvement, modest adverse changes could materially reduce earnings and constrain internally funded investment.
Weak Free Cash FlowThe steep decline in free cash flow shows that working-capital and capital-expenditure needs can absorb much of the company’s earnings. Persistently weak conversion would reduce flexibility for debt reduction, investment and shareholder distributions.
Higher Leverage And Low ReturnsRising reliance on borrowing increases financial sensitivity while the low return on equity indicates that the capital base is generating limited shareholder value. This combination may restrict flexibility if earnings remain volatile or cash generation weakens.
H&R GmbH & Co. KGaA News
2HRA FAQ
What was H&R GmbH & Co. KGaA’s price range in the past 12 months?
Currently, no data Available
What is H&R GmbH & Co. KGaA’s market cap?
H&R GmbH & Co. KGaA’s market cap is CHF235.98M.
When is H&R GmbH & Co. KGaA’s upcoming earnings report date?
H&R GmbH & Co. KGaA’s upcoming earnings report date is Nov 13, 2026 which is in 75 days.
How were H&R GmbH & Co. KGaA’s earnings last quarter?
H&R GmbH & Co. KGaA released its earnings results on Aug 14, 2026. The company reported CHF0.949 earnings per share for the quarter, beating the consensus estimate of CHF0.911 by CHF0.038.
Is H&R GmbH & Co. KGaA overvalued?
According to Wall Street analysts H&R GmbH & Co. KGaA’s price is currently same.
Does H&R GmbH & Co. KGaA pay dividends?
H&R GmbH & Co. KGaA does not currently pay dividends.
What is H&R GmbH & Co. KGaA’s EPS estimate?
H&R GmbH & Co. KGaA’s EPS estimate is 0.
How many shares outstanding does H&R GmbH & Co. KGaA have?
Currently, no data Available
What happened to H&R GmbH & Co. KGaA’s price movement after its last earnings report?
H&R GmbH & Co. KGaA reported an EPS of CHF0.949 in its last earnings report, beating expectations of CHF0.911. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of H&R GmbH & Co. KGaA?
Currently, no hedge funds are holding shares in CH:2HRA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
H&R GmbH & Co. KGaA Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
35.97%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
6.38%
Trailing 12-Months
Company Description
H&R GmbH & Co. KGaA
H&R GmbH & Co. KGaA is a German enterprise specializing in the production and distribution of chemical-pharmaceutical raw materials and precision plastic components, manufactured through injection molding. The company's operations are structured into three primary segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining division is responsible for manufacturing and supplying a diverse array of refined products, including paraffins, white oils, plasticizers, base oils, lubricants, and other specialized crude oil derivatives, as well as feedstocks and bunker fuels. Concurrently, the ChemPharm Sales segment focuses on the processing and commercialization of products such as plasticizers, wax emulsions, paraffins, and similar crude oil-based specialty items. The Plastics division is dedicated to the development, production, and sale of high-precision plastic parts tailored for industries like medical technology, automotive, and various other sectors. H&R's extensive product portfolio also encompasses petroleum jellies, different types of motor and process oils, cable filling compounds, ozone protection waxes, raw materials for the cosmetic and pharmaceutical sectors, mineral oils, and construction insulation materials. Founded in 1919 and headquartered in Salzbergen, Germany, the company transitioned its name to H&R GmbH & Co. KGaA in August 2016, having previously operated as H&R Aktiengesellschaft. It functions as a subsidiary of H&R Komplementär GmbH.